Patent Assignment
Reel/Frame 049940/0607
Change of Name
Recorded: 2019-08-02
Pages: 3
Assignor
BIOVEN 3 LTD.
Executed: 2019-03-14
Assignee
IN3BIO LTD.
2 CHURCH STREET, CLARENDON HOUSE, HAMILTON, HM 11, BERMUDA
Covered Properties
(8)
Recombinant Proteins and Their Therapeutic Uses
Epidermal Growth Factor Fusion Proteins with Mutant Cholera Toxin B Subunits
Methods and Compositions for Inhibition of Egf/Egfr Pathway in Combination with Tyrosine Kinase Inhibitors
Methods and Compositions for Inhibition of Egf/Egfr Pathway in Combination with Tyrosine Kinase Inhibitors
Application:
62/160,183 →
Anti-Egf Antibodies and Their Therapeutic Synergistic Effect on Alk and Mek Inhibitors
Application:
62/715,351 →
Anti-Egf Antibodies and Their Therapeutic Synergistic Effect on Alk and Mek Inhibitors
Application:
62/727,056 →
Anti-Egf Antibodies and Their Therapeutic Synergistic Effect on Alk and Mek Inhibitors
Application:
62/748,772 →
Anti-Egf Antibodies and Their Therapeutic Synergistic Effect on Alk and Mek Inhibitors
Application:
62/760,529 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 4, 2016
From: CHARLTON, KEITH ALAN; D'HONDT, ERIK
To: BIOVEN 3 LIMITED
Reel/Frame 037661/0581 →
Assignment of Assignor's Interest
Feb 4, 2016
From: VERHAMME, DANIEL T.
To: BIOVEN 3 LIMITED
Reel/Frame 037661/0687 →
Assignment of Assignor's Interest
Jun 24, 2016
From: D'HONDT, ERIK; VILA, MIGUEL ÁNGEL MOLINA
To: BIOVEN 3 LIMITED
Reel/Frame 039001/0682 →
Security Interest
Sep 7, 2018
From: BIOVEN 3 LTD.
To: INNOCORP VENTURES SDN. BHD.; HALFMOON BAY CAPITAL LTD
Reel/Frame 046814/0374 →
Assignment of Assignor's Interest
Feb 14, 2019
From: D'HONDT, ERIK; VILA, MIGUEL ÁNGEL MOLINA
To: BIOVEN 3 LIMITED
Reel/Frame 048331/0279 →
Security Interest
Feb 4, 2026
From: IN3BIO LTD.
To: WITHERS BERGMAN LLP
Reel/Frame 074607/0289 →